Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Am J Med. 2013 May;126(5):443–449. doi: 10.1016/j.amjmed.2012.12.016

Table 3.

Demographics and clinical co-morbidities in 379 sickle cell disease patients with no history of venous thromboembolism verses patients with a history of non-catheter-related venous thromboembolism

Variable No Venous Thromboembolism (n = 303) Non-Catheter-Related Venous Thromboembolism (n = 76) p value
Demographics
 Age* (years)
  18–30 117 (38.6) 21 (27.6) 0.144
  31–40 84 (27.7) 21 (27.6)
  41–50 68 (22.4) 19 (25.0)
  51–60 20 (6.6) 11 (14.5)
  >60 14 (4.6) 4 (5.3)
Female 171 (56.4) 52 (68.4) 0.058
 Sickle variant genotype 87 (28.7) 33 (43.4) 0.014
Co-morbidities
 End-stage renal disease 7 (2.3) 3 (3.9) 0.426
 Avascular necrosis 103 (34.0) 35 (46.1) 0.051
 Stroke 37 (12.2) 10 (13.2) 0.823
 Leg Ulcer 28 (9.2) 9 (11.8) 0.495
 Tricuspid regurgitant jet velocity ≥ 2.5 m/s 93 (30.7) 34 (44.7) 0.020

All results expressed as number (percent).

*

Age refers to age at last follow-up.